Oberärztin Kardiologie I, Projektleiterin
Since 2016 | Senior physician; Center of Cardiology – Cardiology I, University Medical Center Mainz (Prof. Dr. med. Th. Münzel) |
2015 | Board Exam Internal Medicine |
2010-2012 | Research Fellowship in the Institute of Molecular Medicine, University Medical Center Mainz (Prof. Ari Waisman); Research fellowship Margarethe-Waitz-Foundation |
2008-2015 | Residency in internal medicine / cardiology; Center of Cardiology – Cardiology I, University Medical Center Mainz (Prof. Dr. med. Th. Münzel) |
2003-2005 | Doctoral degree in Medical Sciences (Dr. med.), supervision by Prof. Dr. rer. nat. E. Closs und Prof. Dr. med. U. Förstermann, Department of Pharmacology, Johannes Gutenberg-Universität Mainz, Germany (Summa cum laude); Research fellowship Robert-Müller-Foundation |
2000-2007 | Medical student, Johannes Gutenberg-Universität Mainz, Germany, University Medical Center Örebro, Sweden and Université de Bourgogne, Dijon, France |
2000 | German high school diploma, Eduard-Spranger Gymnasium Landau/Pfalz, Germany |
2015 | Boehringer-Ingelheim Award |
2013 | Pre-clinical Award of the Foundation Mainzer Herz |
2000 | Award for the best high school diploma of the school and for excellent performance in modern languages (French and English) |
2017-2020 | Research Consortium Grant of the Boehringer Ingelheim Foundation: Novel and neglected cardiovascular risk factors – Molecular mechanisms and therapeutic implications. Project 3: Impact of skin inflammation on cardiovascular health. |
2015-2017 | Scientific Funding by the Translational Research Program (Project X.II) CTH Mainz, BMBF: Interleukin-6 in the development of venous thrombosis. |
Since 2014 | Grant of the German Research Foundation (KA 4035/1-1): The role of interleukin-6 (IL-6) and the interaction between IL-6 and interleukin-17 (IL-17) in the development of vascular inflammation and vascular dysfunction. |
2012-2014 | Research Funding of the Inneruniversitäre Forschungsförderung, University Medical Center Mainz: Influence of vascular function by deletion of the Interleukin-6 Receptor alpha on myelomonocytic cells and CD4+ T cells in mice. |
2010-2012 | MAIFOR Research Funding, University Medical Center Mainz: The role of Interleukin-17 in the development of arterial hypertension. |
2010 | Scientific Funding by the Foundation Mainzer Herz: The role of Interleukin-17A in the development of hypertension in context of the general contribution of the immune system to the development of endothelial dysfunction. |